She said using antibodies as 'magic bullets' had been clinically difficult, and the mTCRs were difficult to make and had all the same problems as monoclonal antibodies.
Ernst Schaefer, a nutrition researcher at Tufts University who is involved in Accomplia studies, said none of these obesity drugs are going to be magicbullets.
